Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Over-Allotment Option Over-Allotment Option [Member] Variable Rate [Domain] Variable Rate [Domain] Pay vs Performance Disclosure [Line Items] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Range [Domain] Statistical Measurement [Domain] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Expiration period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Equity Award [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Equity award other than options, nonvested (in shares) Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Line of credit facility, interest rate (as a percent) Line of Credit Facility, Interest Rate at Period End Long Term Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Cash, Cash Equivalents and Available-for-Sale Marketable Securities Cash, Cash Equivalents and Investments [Table Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance-based restricted stock units Performance-Based Restricted Stock Units (PSUs) Performance-based restricted stock units Performance Shares [Member] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Corporate Debt Securities Corporate Debt Securities [Member] Insider Trading Policies and Procedures [Line Items] Exercisable at the ending of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Customer B Customers B [Member] Customers B Proceeds from issuance or sale of equity Proceeds from Issuance or Sale of Equity Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Variable Rate Component One Variable Rate Component One [Member] Variable Rate Component One Stockholders' Equity Equity [Text Block] Beneficial ownership threshold percentage Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Accrued Liabilities, Current [Abstract] Accrued Liabilities, Current [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Concentration Risk [Line Items] Concentration Risk [Line Items] Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at September 30, 2024 and December 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively Preferred Stock, Value, Issued Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Diluted net loss per common share (in dollars per share) Earnings Per Share, Diluted Schedule of Investments [Table] Schedule of Investments [Table] PEO Total Compensation Amount PEO Total Compensation Amount Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Loan Facility, Tranche 4 Loan Facility, Tranche Four [Member] Loan Facility, Tranche Four Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Line of Credit Line of Credit [Member] Outstanding at the beginning of the year (in shares) Outstanding at the ending of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average grant date fair value of options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Net loss Net Loss Net loss Net Income (Loss) Attributable to Parent Total current liabilities Liabilities, Current 2024 Sales Agreement And Sales Agreement Amendment 2024 Sales Agreement And Sales Agreement Amendment [Member] 2024 Sales Agreement And Sales Agreement Amendment Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Gross to net accrued liabilities Accrued Liabilities, Gross Accrued Liabilities, Gross Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Stock price discount per share (in dollars per share) Class Of Warrant Or Right, Stock Price Discount Per Common Share Class Of Warrant Or Right, Stock Price Discount Per Common Share Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Amortization and interest accretion related to operating leases Operating Lease, Right-Of-Use Asset, Periodic Reduction (Increase) Operating Lease, Right-Of-Use Asset, Periodic Reduction (Increase) Executive Category: Executive Category [Axis] Eligible to Earn PSUs Eligible to Earn Performance Share [Member] Eligible to Earn Performance Share Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Name Measure Name Line of credit facility, current borrowing capacity Line of Credit Facility, Current Borrowing Capacity Name Forgone Recovery, Individual Name Hercules warrant Adjustments to Additional Paid in Capital, Warrant Issued Equity Components [Axis] Equity Components [Axis] Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Major Types of Debt and Equity Securities [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Accrued liabilities Increase (Decrease) in Accrued Liabilities Shares available for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2026 Long-Term Debt, Maturity, Year Two Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Corporate Debt Securities Due Within 1 To 2 Years of Date of Purchase Corporate Debt Securities Due Within One To Two Years Of Date Of Purchase [Member] Corporate Debt Securities Due Within One To Two Years Of Date Of Purchase Local Phone Number Local Phone Number Trade receivables, net Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Selling, general and administrative Selling, General and Administrative Expenses [Member] 2024 Long-Term Debt, Maturity, Remainder of Fiscal Year Warrants Warrant [Member] Lease liability Operating Lease, Liability, Noncurrent Restricted stock units Restricted Stock Units (RSUs) Restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of RSU Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Accounts payable Increase (Decrease) in Accounts Payable, Trade Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Payment of debt issuance costs Payments of Debt Issuance Costs Income Statement Location [Axis] Income Statement Location [Axis] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Number of votes per share that common stockholders are entitled to receive Common Stock Voting Rights Number Represents the number of votes per share that common stockholders are entitled to receive. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Liquidity and Uncertainties Substantial Doubt about Going Concern [Text Block] Product revenue, net Revenues Schedule of the Outstanding Securities not Included in the Computation of Diluted Net Loss Per Common Share as their Inclusion would be Anti-dilutive Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventory Increase (Decrease) in Inventories Research and development Research and Development Expense [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Sale of stock received on transaction, gross Sale Of Stock, Consideration Received On Transaction, Gross Sale Of Stock, Consideration Received On Transaction, Gross Manufacturing and drug supply Accrued Manufacturing and Drug Supply Current Accrued manufacturing and drug supply Current. Award Type [Axis] Award Type [Axis] Outstanding securities not included in the computation of diluted net loss per common share as their inclusion would be anti-dilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in shares) PSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Obtaining a right-of-use asset in exchange for a lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Trading Arrangement: Trading Arrangement [Axis] Schedule of PSU Activity Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount 2024 Public Stock Offering Public Offering, 2024 [Member] Public Offering, 2024 Cost Cash, Cash Equivalents, and Short-term Investments, At Cost This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings, and cash and cash equivalents. Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Marketable securities: Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Less unamortized discount Debt Instrument, Unamortized Discount Lease liability Operating Lease, Liability, Current Sales and maturities of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Entity Shell Company Entity Shell Company Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Intangible assets, net Finite-Lived Intangible Assets, Net Restatement Determination Date Restatement Determination Date Loan Facility, Tranches 2 and 3 Loan Facility, Tranches Two and Three [Member] Loan Facility, Tranches Two and Three Counterparty Name [Domain] Counterparty Name [Domain] Line of credit facility, increase In maximum borrowing capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Minimum liquidity covenant Debt Instrument, Covenant, Liquidity, Minimum Debt Instrument, Covenant, Liquidity, Minimum Liquidity and Uncertainties Liquidity and Uncertainties Liquidity And Uncertainties Disclosure Abstract Shares issued (in dollars per share) Sale of Stock, Price Per Share Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, shares issued (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Issued Vested (in shares) PSUs attained (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Term charges on aggregate principal amount, (as a percent) Line of Credit Facility, Commitment Fee Percentage Security Exchange Name Security Exchange Name Loans payable, net of discount Long-Term Debt Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Cash received on stock transaction after deduction of issuance costs Sale of Stock, Consideration Received on Transaction Selling, general and administrative Selling, General and Administrative Expense Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Common stock options Stock Options Stock options Share-Based Payment Arrangement, Option [Member] Accrued interest payments, term (in months) Debt Instrument, Accrued Interest Payments, Term Debt Instrument, Accrued Interest Payments, Term Weighted average remaining period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Unrecognized stock compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Inventory Inventory, Policy [Policy Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock-based Compensation Share-Based Payment Arrangement [Text Block] 2015 Stock Plan And Inducement Plan Two Thousand And Fifteen Stock And Inducement Plan [Member] Two thousand and fifteen stock and inducement plan. Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Hoffmann-La Roche ("Roche") Hoffman La Roche [Member] Represents information pertaining to Hoffman-La Roche. Long term debt floor interest rate (as a percent) Long Term Debt Floor Interest Rate Percentage Long term debt floor interest rate percentage. Customer Concentration Risk Customer Concentration Risk [Member] Preferred stock conversion ratio (in shares) Preferred Stock, Convertible, Conversion Ratio Variable Rate [Axis] Variable Rate [Axis] Loan Facility, Tranche 3 Loan Facility, Tranche Three [Member] Loan Facility, Tranche Three Cash Cash [Member] Income Statement [Abstract] Income Statement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Cash and cash equivalents: Schedule of Investments [Line Items] Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares) Stock Issued During Period, Shares, New Issues Operating expenses: Costs and Expenses [Abstract] Options cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Total cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Related Party, Type [Domain] Related Party, Type [Domain] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Weighted average grant date fair value (in dollars per share) Unvested, beginning balance (in dollars per share) Unvested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Taxes Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventory Total Inventory, Net Statistical Measurement [Axis] Statistical Measurement [Axis] Less amount representing interest Interest Expense, Debt, Excluding Amortization Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Inventory Disclosure [Abstract] Unrecognized stock-based compensation expense Stock-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Valuation allowance on deferred tax assets (as a percent) Deferred Tax Assets, Percentage Of Valuation Allowance The percentage of valuation allowance on the deferred tax assets. Convertible Series A and B Preferred Stock Convertible Series A and B Preferred Stock [Member] Convertible Series A and B Preferred Stock [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Research, Development and Commercialization Agreement Research Development And Commercialization Agreement [Member] Represents information pertaining to Research, Development and Commercialization Agreement with Hoffmann-La Roche ("Roche") which grants a sole and exclusive license to develop, use, sell, offer for sale and import any Licensed Product as defined by the agreement. Debt instrument, face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Unrealized gain (loss) on available-for-sale securities Unrealized (loss) gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Milestone payment due Collaborative Arrangement, Contingent Consideration, Liability, Milestone Payment Collaborative Arrangement, Contingent Consideration, Liability, Milestone Payment Concentrations of Credit Risk and Significant Customers Concentration Risk, Credit Risk, Policy [Policy Text Block] Proceeds from issuance of loan payable Proceeds from Bank Debt Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Schedule of Inventory Balances Schedule of Inventory, Current [Table Text Block] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Credit Facility [Axis] Credit Facility [Axis] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Organization, Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Customer A Customer A [Member] Customer A Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Fair value Cash, Cash Equivalents, and Short-Term Investments Common stock, capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance All Executive Categories All Executive Categories [Member] Long term liabilities: Liabilities, Noncurrent [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Line of credit facility, number of withdrawals upon milestone achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Plan Name [Axis] Plan Name [Axis] Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net loss per common share: Earnings Per Share [Abstract] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Marketable Securities Marketable Securities, Policy [Policy Text Block] Common stock, par value $0.0001 per share authorized: 200,000,000 at September 30, 2024 and December 31, 2023; 21,806,436 and 19,875,427 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Professional fees Accrued Professional Fees, Current Beneficial ownership notice period (in days) Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] 2021 Sales Agreement Two Thousand and Twenty One Sales Agreement [Member] Two thousand and twenty one sales agreement. Total current assets Assets, Current Cowen & Co. LLC Cowen Co. Llc [Member] Represent of Cowen & Co. LLC Member. Preferred stock Preferred stock Preferred Stock [Member] 2023 Inducement Plan Inducement Plan 2023 [Member] Two Thousand And Twenty Three Stock Inducement Plan [Member] Schedule of Concentrations of Credit Risk and Significant Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Restricted cash Restricted Cash All Individuals All Individuals [Member] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Purchasing period Sale Of Stock, Purchasing Period Sale Of Stock, Purchasing Period Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Basic and Diluted Loss Per Common Share Earnings Per Share, Policy [Policy Text Block] Authorized capital Stock Repurchase Program, Authorized Amount Variable Rate Component Two Variable Rate Component Two [Member] Variable Rate Component Two Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] PEO Name PEO Name Concentration risk, percentage (as a percent) Concentration Risk, Percentage Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Granted (in dollars per share) PSUs granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value U.S. Government and Government Sponsored Entities US Treasury and Government [Member] Restricted cash Restricted Cash, Current Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Stock-based compensation expense related to equity-classified awards and Compensation expense related to stock options for services APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Marketable securities Debt Securities, Available-for-Sale, Current Other Other Accrued Liabilities, Current Depreciation and amortization expense Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity Balance Balance Equity, Attributable to Parent 2015 Stock Plan Stock Plan 2015 [Member] Two thousand and fifteen stock plan Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock granted and issuable (in shares) Common Stock, Capital Shares Granted And Issuable Common Stock, Capital Shares Granted And Issuable Subsequent Events [Abstract] Subsequent Events [Abstract] Acquisition of intangible asset Payments to Acquire Intangible Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Entity Emerging Growth Company Entity Emerging Growth Company Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Line of credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Outstanding at the beginning of the year (in dollars per share) Outstanding at the ending of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] Revenue from Contract with Customer, Product and Service Benchmark Revenue from Contract with Customer, Product and Service Benchmark [Member] Patents Patents [Policy Text Block] Disclosure of accounting policy for patents. Document Fiscal Year Focus Document Fiscal Year Focus Property and equipment, net Property, Plant and Equipment, Net Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Nonrelated Party Nonrelated Party [Member] Loan Facility, Tranche 1 Loan Facility, Tranche One [Member] Loan Facility, Tranche One Loan Facility Loan Facility [Member] Loan facility member. Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Cost Debt Securities, Available-for-Sale, Amortized Cost Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Richard Levy [Member] Richard Levy Basic net loss per common share (in dollars per share) Earnings Per Share, Basic Right-of-use asset Operating Lease, Right-of-Use Asset Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sale of Stock [Domain] Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Other clinical study related costs Accrued Other Clinical Study Related Costs Current Accrued other clinical study related costs current. Total intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value 2023 Public Stock Offering Public Offering, 2023 [Member] Public Offering, 2023 Number of warrants issued for purchase of common shares (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Party Related Party [Member] U.S. Government and Government Sponsored Entities Due Within 1 Year of Date of Purchase US Treasury And Government Due Within One Year [Member] US Treasury And Government Due Within One Year Principle of Consolidation Consolidation, Policy [Policy Text Block] Total long term liabilities Liabilities, Noncurrent Proceeds from issuance of debt Proceeds from Issuance of Debt Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Hercules Warrants Hercules Warrants [Member] Hercules Warrants Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Fair value Debt Securities, Available-for-Sale Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Long-term debt Long-Term Debt, Gross Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Forfeited (in dollars per share) PSUs forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Proceeds resulting from exercise of stock options Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Options cancelled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited (in shares) PSUs forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Insider Trading Arrangements [Line Items] 2025 Long-Term Debt, Maturity, Year One Related Party, Type [Axis] Related Party, Type [Axis] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Warrants and rights outstanding Warrants and Rights Outstanding Remainder of future milestone payments Remaining Milestone Payments The amount of future milestone payments remaining to be paid under the agreement. Adjustment to Compensation, Amount Adjustment to Compensation Amount Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Exercisable at the ending of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Loan Facility, Tranche 2 Loan Facility, Tranche Two [Member] Loan Facility, Tranche Two Stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Finished goods Inventory, Finished Goods, Net of Reserves Beneficial ownership maximum percentage Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Compensation and benefits Employee-related Liabilities, Current Name Trading Arrangement, Individual Name Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Cost of sales Operating Costs and Expenses Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs Stock Issued During Period, Value, New Issues Equity [Abstract] Inventory Inventory Disclosure [Text Block] Product revenue, net Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Thereafter Long-Term Debt, Maturity After Year Two Long-Term Debt, Maturity After Year Two U.S. government and government sponsored entities due within 1 to 2 years of date of purchase US Treasury And Government Due Within One To Two Years [Member] US Treasury And Government Due Within One To Two Years Money Market Funds Money Market Funds [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Credit Facility [Domain] Credit Facility [Domain] Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Loan payable, net of discount Long-Term Debt, Excluding Current Maturities Diluted weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Contract research organization costs Accrued Contract Research Costs Current Accrued Contract Research Costs, Current. Accrued interest, net of interest received on maturity of investments Increase (Decrease) In Accrued Interest, Net Of Interest Received The increase (decrease) during the reporting period in the aggregate amount of accrued interest expense incurred but not yet paid, net of interest received on maturity of investments. Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Realized gains or losses on marketable securities Debt Securities, Available-for-Sale, Realized Gain (Loss) Purchases of property and equipment, net of disposals Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in-capital Additional Paid in Capital, Common Stock Additional paid-in Capital Additional Paid-in Capital [Member] Maximum aggregate offering price Common Stock Aggregate Offering Price Represents the maximum aggregate offering price the entity may issue and sell shares of its common stock from time to time, at the entity's option, according to at-the-market issuance sales agreement with third party. Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Cover [Abstract] Pre-funded warrants Pre Funded Warrants [Member] Pre FundedWarrants [Member] Subsequent Events Subsequent Events [Text Block] Line of credit facility, decrease In maximum borrowing capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Vested (in dollars per share) PSUs attained (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Total operating expenses Operating Expenses Prime Rate Prime Rate [Member] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Secured Debt Secured Debt [Member] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Work in process Inventory, Work in Process, Net of Reserves Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Customer C Customers C [Member] Customers C Debt Instrument [Line Items] Commitments and Contingencies Debt Instrument [Line Items] Basic weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenues: Revenues [Abstract] Preferred shares number voting rights Preferred Stock, Number Of Voting Rights Number of voting rights of preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. Customer D Customers D [Member] Customers D 2024 Sales Agreement 2024 Sales Agreement [Member] 2024 Sales Agreement Stockholders' Equity (Deficit) Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table]